2015
DOI: 10.1155/2015/160473
|View full text |Cite
|
Sign up to set email alerts
|

Leclercia adecarboxylataMusculoskeletal Infection in an Immune Competent Pediatric Patient: An Emerging Pathogen?

Abstract: Case. An immune competent pediatric patient presented with a persistent lower extremity infection with Leclercia adecarboxylata after a penetrating injury. This case report details the presentation, clinical course, and treatment. Conclusion. Leclercia adecarboxylata has increasing reports in immunosuppressed and adult patients with musculoskeletal infection. This case now indicates that Leclercia adecarboxylata is a potential pathogen in immune competent children in musculoskeletal tissue.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0
4

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(20 citation statements)
references
References 10 publications
0
16
0
4
Order By: Relevance
“…Isolation of L. adecarboxylata from an immunocompetent paediatric patient was reported (Grantham et al . ). The bacteria showed excellent susceptibility to antibiotics.…”
Section: Resultsmentioning
confidence: 97%
“…Isolation of L. adecarboxylata from an immunocompetent paediatric patient was reported (Grantham et al . ). The bacteria showed excellent susceptibility to antibiotics.…”
Section: Resultsmentioning
confidence: 97%
“…Se ha asociado con brotes nosocomiales de artritis y bacteriemia en pacientes inmunocompetentes, aunque esta situación es rara. 2,4,5 Afecta, generalmente, a sujetos con cierto grado de inmunosupresión como agente oportunista y en el contexto de infecciones polimicrobianas, 8 al igual que en nuestro paciente, con coinfección con C. parasilopsis. Del mismo modo, las infecciones por R. ornithinolytica se han descrito en diabéticos, pacientes oncológicos 9,10 e inmunodeprimidos.…”
Section: Discussionunclassified
“…1 Es ubicuo en la naturaleza; está presente en las aguas, en los líquidos orgánicos y en el tracto gastrointestinal tanto humano como animal. 2,3 Se ha descrito como agente productor de bacteriemia, peritonitis, 4 infecciones de piel y tejidos blandos (IPTB), 4 neumonía, endocarditis, 2 absceso periamigdalino 5 y colecistitis, entre otros.…”
Section: Introductionunclassified
See 1 more Smart Citation
“…İmmün yetmezlikli hastalarda fırsatçı patojen olarak tek başına, immün yetmezliği olmayan hasta grubunda ise polimikrobiyal enfeksiyon etkeni olarak görüldüğü bildirilmiştir 1,3,4 . Özellikle travma sonrası alt ekstremite enfeksiyonlarına neden olduğu bildirilmiştir [5][6][7] . Ayrıca sıklıkla periton diyalizine bağlı olarak peritonit etkeni olarak bildirilmiştir 8,9 .…”
Section: Olgu Sunumuunclassified